These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 29653075

  • 1. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL, Chuang LM, Li HY.
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC, Collison A, Russo RC, Foot JS, Yow TT, Vieira AT, Tavares LD, Mattes J, Teixeira MM, Jarolimek W.
    Respir Res; 2015 Mar 20; 16(1):42. PubMed ID: 25889951
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of semicarbazide-sensitive amine oxidase induces the phenotypic switch of smooth muscle cells and aggravates the development of atherosclerotic lesions.
    Zhang M, Liu L, Zhi F, Niu P, Yang M, Zhu X, Diao Y, Li Y, Wang J, Zhao Y.
    Atherosclerosis; 2016 Jun 20; 249():76-82. PubMed ID: 27065245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.
    Wong MY, Saad S, Wong MG, Stangenberg S, Jarolimek W, Schilter H, Zaky A, Gill A, Pollock C.
    PLoS One; 2020 Jun 20; 15(6):e0234617. PubMed ID: 32555665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
    Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D.
    Biochim Biophys Acta; 2003 Apr 11; 1647(1-2):193-9. PubMed ID: 12686132
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.
    Peng Y, Wang J, Zhang M, Niu P, Yang M, Yang Y, Zhao Y.
    PLoS One; 2016 Apr 11; 11(4):e0152758. PubMed ID: 27043821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM, Wang E, O'Rourke AM, Miller A, Gao H, Huang L, Garcia A, Linnik MD.
    J Pharmacol Exp Ther; 2005 Nov 11; 315(2):553-62. PubMed ID: 16081681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P, Solé M, Unzeta M.
    Cerebrovasc Dis; 2014 Nov 11; 37(3):171-80. PubMed ID: 24503888
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
    Sun P, Hernandez-Guillamón M, Campos-Martorell M, Simats A, Montaner J, Unzeta M, Solé M.
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb 11; 1864(2):542-553. PubMed ID: 29175057
    [Abstract] [Full Text] [Related]

  • 15. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
    Wong M, Saad S, Zhang J, Gross S, Jarolimek W, Schilter H, Chen JA, Gill AJ, Pollock CA, Wong MG.
    Am J Physiol Renal Physiol; 2014 Oct 15; 307(8):F908-16. PubMed ID: 25143459
    [Abstract] [Full Text] [Related]

  • 16. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R, Li H, Luo HJ, Lin ZX, Jiang ZW, Luo WH.
    Cell Immunol; 2013 Oct 15; 283(1-2):61-9. PubMed ID: 23850964
    [Abstract] [Full Text] [Related]

  • 17. Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice.
    Dai X, Ou X, Hao X, Cao D, Tang Y, Hu Y, Li X, Tang C.
    Acta Biochim Biophys Sin (Shanghai); 2008 Mar 15; 40(3):261-8. PubMed ID: 18330481
    [Abstract] [Full Text] [Related]

  • 18. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ, Bhatnagar A, Cowley HR, Johnson GH, Wiechmann RJ, Sayre LM, Trent MB, Boor PJ.
    Toxicol Appl Pharmacol; 2006 Dec 15; 217(3):277-88. PubMed ID: 17095030
    [Abstract] [Full Text] [Related]

  • 19. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
    Solé M, Unzeta M.
    Biol Cell; 2011 Nov 15; 103(11):543-57. PubMed ID: 21819380
    [Abstract] [Full Text] [Related]

  • 20. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses.
    O'Sullivan J, O'Sullivan M, Tipton KF, Unzeta M, Del Mar Hernandez M, Davey GP.
    Biochim Biophys Acta; 2003 Apr 11; 1647(1-2):367-71. PubMed ID: 12686159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.